Norfluoxetine inhibits TREK-2 K2P channels by multiple mechanisms including state-independent effects on the selectivity filter gate by Proks, P, Schewe, M, Conrad, LJ, Rao, S, Rathje, K, Rödström, KEJ, Carpenter, EP, Baukrowitz, T, Tucker, SJ

Extracellular modulation of TREK-2 activity with nanobodies provides insight into the mechanisms of K2P channel regulation by Rödström, KEJ, Cloake, A, Sörmann, J, Baronina, A, Smith, KHM, Pike, ACW, Ang, J, Proks, P, Schewe, M, Holland-Kaye, I, Bushell, SR, Elliott, J, Pardon, E, Baukrowitz, T, Owens, RJ, Newstead, S, Steyaert, J, Carpenter, EP, Tucker, SJ

Structure and function of the SIT1 proline transporter in complex with the COVID-19 receptor ACE2 by Li, HZ, Pike, ACW, Lotsaris, I, Chi, G, Hansen, JS, Lee, SC, Rödström, KEJ, Bushell, SR, Speedman, D, Evans, A, Wang, D, He, D, Shrestha, L, Nasrallah, C, Burgess-Brown, NA, Vandenberg, RJ, Dafforn, TR, Carpenter, EP, Sauer, DB

Gain-of-function mutations in KCNK3 cause a developmental disorder with sleep apnea by Sörmann, J, Schewe, M, Proks, P, Jouen-Tachoire, T, Rao, S, Riel, EB, Agre, KE, Begtrup, A, Dean, J, Descartes, M, Fischer, J, Gardham, A, Lahner, C, Mark, PR, Muppidi, S, Pichurin, PN, Porrmann, J, Schallner, J, Smith, K, Straub, V, Vasudevan, P, Willaert, R, Carpenter, EP, Rödström, KEJ, Hahn, MG, Müller, T, Baukrowitz, T, Hurles, ME, Wright, CF, Tucker, SJ